Advanced search
Publication Cover
Infection and Drug Resistance Volume 12, 2019 - Issue
Submit an article Journal homepage
450
Views
42
CrossRef citations to date
0
Altmetric
Review

Recombinant human papillomavirus nonavalent vaccine in the prevention of cancers caused by human papillomavirus

Zheng Quan Toh1 Infection and Immunity, Murdoch Children’s Research Institute, Parkville, Victoria, Australia;2 Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia
,
Jennie Kosasih1 Infection and Immunity, Murdoch Children’s Research Institute, Parkville, Victoria, Australia
,
Fiona M Russell1 Infection and Immunity, Murdoch Children’s Research Institute, Parkville, Victoria, Australia;3 Centre for International Child Health, Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia
,
Suzanne M Garland4 Department of Obstetrics and Gynaecology, The University of Melbourne, Parkville, Victoria, Australia;5 Regional WHO HPV Reference Laboratory, Centre for Women’s Infectious Diseases Research, The Royal Women’s Hospital, Parkville, Victoria, Australia
,
Edward K Mulholland1 Infection and Immunity, Murdoch Children’s Research Institute, Parkville, Victoria, Australia;6 Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, University of London, LondonWC1E7HT, UK
&
Paul V Licciardi1 Infection and Immunity, Murdoch Children’s Research Institute, Parkville, Victoria, Australia;2 Department of Paediatrics, The University of Melbourne, Parkville, Victoria, AustraliaCorrespondence[email protected]
Pages 1951-1967 | Published online: 04 Jul 2019

Citations (42)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Reisa Kakubari, Tomomi Egawa-Takata, Yutaka Ueda, Yusuke Tanaka, Asami Yagi, Akiko Morimoto, Yoshito Terai, Masahide Ohmichi, Tomoyuki Ichimura, Toshiyuki Sumi, Hiromi Murata, Hidetaka Okada, Hidekatsu Nakai, Noriomi Matsumura, Kiyoshi Yoshino, Tadashi Kimura, Junko Saito, Risa Kudo, Masayuki Sekine, Takayuki Enomoto, Yorihiko Horikoshi, Tetsu Takagi & Kentaro Shimura. (2021) A survey of 20-year-old Japanese women: how is their intention to undergo cervical cancer screening associated with their childhood HPV vaccination status?. Human Vaccines & Immunotherapeutics 17:2, pages 434-442.
Read now

Articles from other publishers (41)

David van Bockel & Anthony Kelleher. (2023) The crossroads: divergent roles of virus‐specific CD4 + T lymphocytes in determining the outcome for human papillomavirus infection . Immunology & Cell Biology 101:6, pages 525-534.
Crossref
Soumya Dakshinamurthy, Rishi Gowtham Racherla, Praveen Belagal, T. Bharathi & D. V. R. Sai Gopal. (2023) Detection and Partial Molecular Characterization (E6–E7 Region-Early Genes) and Prevalence of Human Papillomavirus (HPV) Causing Cervical Cancer in and Around Tirupati Region, Andhra Pradesh. Indian Journal of Gynecologic Oncology 21:2.
Crossref
Stephanie M. Wang, Emma A. Keegan, Katherine M. Bryan, Jamil Kazma, Kirsten J.H. Das, Beverly J. Long & Anna BuAbbud. (2023) Human papillomavirus vaccination receipt and provider counseling rates among high-risk patients. Vaccine 41:18, pages 2961-2967.
Crossref
Yvonne Nartey, Kwabena Amo-Antwi, Philip C. Hill, Edward T. Dassah, Richard H. Asmah, Kofi M. Nyarko, Ramatu Agambire, Thomas O. Konney, Joel Yarney, Nelson Damale & Brian Cox. (2023) Human papillomavirus genotype distribution among women with and without cervical cancer: Implication for vaccination and screening in Ghana. PLOS ONE 18:1, pages e0280437.
Crossref
Caitlin Swift, Aditi Dey, Harunor Rashid, Katrina Clark, Ramesh Manocha, Julia Brotherton & Frank Beard. (2022) Stakeholder Perspectives of Australia’s National HPV Vaccination Program. Vaccines 10:11, pages 1976.
Crossref
Queenie Fernandes, Soumaya Allouch, Ishita Gupta, Ibrahim Elmakaty, Khaled E. Elzawawi, Ahmed Amarah, Hamda Al-Thawadi, Halema Al-Farsi, Semir Vranic & Ala-Eddin Al Moustafa. (2022) Human Papillomaviruses-Related Cancers: An Update on the Presence and Prevention Strategies in the Middle East and North African Regions. Pathogens 11:11, pages 1380.
Crossref
Ciying Qian, Yurou Yang, Qin Xu, Zhiping Wang, Jie Chen, Xin Chi, Miao Yu, Fei Gao, Yujie Xu, Yihan Lu, Hui Sun, Jingjia Shen, Daning Wang, Lizhi Zhou, Tingting Li, Yingbin Wang, Qingbing Zheng, Hai Yu, Jun Zhang, Ying Gu, Ningshao Xia & Shaowei Li. (2022) Characterization of an Escherichia coli-derived triple-type chimeric vaccine against human papillomavirus types 39, 68 and 70. npj Vaccines 7:1.
Crossref
Mette T. Faber, Kirsten Frederiksen, Joel M. Palefsky & Susanne K. Kjaer. (2022) A nationwide longitudinal study on risk factors for progression of anal intraepithelial neoplasia grade 3 to anal cancer. International Journal of Cancer 151:8, pages 1240-1247.
Crossref
Dmitry E. Mikhalev, Olga D. Baydik, Marat R. Mukhamedov & Georgy O. Aleksandrov. (2022) The role of the human papilloma virus in the development of potentially malignant diseases and squamous cell carcinomas of the oral mucosa. Russian Journal of Dentistry 26:3, pages 267-276.
Crossref
Maryam Koopaie, Mohamad Amin Nematollahi, Maryam Dadar & Soheila Manifar. (2022) Lineage and phylogenetic analysis of HPV-16, -18 in saliva of HNSCC patients. Brazilian Journal of Oral Sciences 21, pages e226337.
Crossref
Jingyi Fan, Shengbin Jin, Lachlan Gilmartin, Istvan Toth, Waleed M. Hussein & Rachel J. Stephenson. (2022) Advances in Infectious Disease Vaccine Adjuvants. Vaccines 10:7, pages 1120.
Crossref
Niloofar Khairkhah, Azam Bolhassani & Reza Najafipour. (2022) Current and future direction in treatment of HPV-related cervical disease. Journal of Molecular Medicine 100:6, pages 829-845.
Crossref
Ridhima Jasrotia, Daljeet Singh Dhanjal, Sonali Bhardwaj, Parvarish Sharma, Chirag Chopra, Reena Singh, Anupam Kumar, Anamika Mubayi, Deepak Kumar, Raj Kumar & Abhineet Goyal. (2022) Nanotechnology based vaccines: Cervical cancer management and perspectives. Journal of Drug Delivery Science and Technology 71, pages 103351.
Crossref
Francesco MUSCIANISI, Carlo FORESTA & Andrea GAROLLA. (2022) Role of HPV vaccination for prevention of male infertility. Minerva Endocrinology 47:1.
Crossref
Alexandre Santos Matos, Fernanda Oliveira Prado, Paloma Aparecida Santos Rocha & Marcus Vinicius Aragão Batista. (2022) Immunoinformatics-based characterization of immunogenic CD8 T-cell epitopes for a broad-spectrum cell-mediated immunity against high-risk human papillomavirus infection. Microbial Pathogenesis 165, pages 105462.
Crossref
Ulrike Wieland & Alexander Kreuter. (2022) Impfprävention HPV-assoziierter NeoplasienVaccine-mediated prevention of HPV-associated neoplasms. Forum 37:2, pages 135-141.
Crossref
Ulrike Wieland & Alexander Kreuter. (2022) Prävention HPV-induzierter Erkrankungen durch prophylaktische ImpfungPrevention of HPV-induced diseases by prophylactic vaccination. best practice onkologie 17:4, pages 160-168.
Crossref
Lauren M. Hook, Sita Awasthi, Tina M. Cairns, Mohamad-Gabriel Alameh, Bernard T. Fowler, Kevin P. Egan, Molly M. H. Sung, Drew Weissman, Gary H. Cohen & Harvey M. Friedman. (2022) Antibodies to Crucial Epitopes on HSV-2 Glycoprotein D as a Guide to Dosing an mRNA Genital Herpes Vaccine. Viruses 14:3, pages 540.
Crossref
Tofan Widya Utami, Andrijono Andrijono, Andi Putra, Junita IndartiGert Fleuren, Ekaterina Jordanova, Inas Humairah & Ahmad Utomo. (2022) Possible different genotypes for human papillomavirus vaccination in lower middle-income countries towards cervical cancer elimination in 2030: a cross-sectional study. Clinical and Experimental Vaccine Research 11:2, pages 141.
Crossref
Emma R. Allanson & Kathleen M. Schmeler. (2021) Preventing Cervical Cancer Globally: Are We Making Progress?. Cancer Prevention Research 14:12, pages 1055-1060.
Crossref
Supitcha Kamolratanakul & Punnee Pitisuttithum. (2021) Human Papillomavirus Vaccine Efficacy and Effectiveness against Cancer. Vaccines 9:12, pages 1413.
Crossref
Amr Mohamed Ouda, Ahmed Adel Elsabagh, Ibrahim Mohamed Elmakaty, Ishita Gupta, Semir Vranic, Hamda Al-Thawadi & Ala-Eddin Al Moustafa. (2021) HPV and Recurrent Respiratory Papillomatosis: A Brief Review. Life 11:11, pages 1279.
Crossref
EMMA R. ALLANSON & KATHLEEN M. SCHMELER. (2021) Cervical Cancer Prevention in Low- and Middle-Income Countries. Clinical Obstetrics & Gynecology 64:3, pages 501-518.
Crossref
Zheng Quan Toh, Chau Quang, Joseph A. Tooma, Suzanne M. Garland, Kim Mulholland & Paul V. Licciardi. (2021) Australia’s Role in Pneumococcal and Human Papillomavirus Vaccine Evaluation in Asia-Pacific. Vaccines 9:8, pages 921.
Crossref
Katharine J. Bee, Ana Gradissimo, Zigui Chen, Ariana Harari, Mark Schiffman, Tina Raine-Bennett, Philip E. Castle, Megan Clarke, Nicolas Wentzensen & Robert D. Burk. (2021) Genetic and Epigenetic Variations of HPV52 in Cervical Precancer. International Journal of Molecular Sciences 22:12, pages 6463.
Crossref
Scott Christley, Jared Ostmeyer, Lisa Quirk, Wei Zhang, Bradley Sirak, Anna R. Giuliano, Song Zhang, Nancy Monson, Jasmin Tiro, Elena Lucas & Lindsay G. Cowell. (2021) T Cell Receptor Repertoires Acquired via Routine Pap Testing May Help Refine Cervical Cancer and Precancer Risk Estimates. Frontiers in Immunology 12.
Crossref
Ulrike Wieland & Alexander Kreuter. (2020) Prävention HPV-induzierter Erkrankungen durch prophylaktische ImpfungPrevention of HPV-induced diseases by prophylactic vaccination. Der Hautarzt 72:2, pages 106-113.
Crossref
Ulrike Wieland, Frank Oellig & Alexander Kreuter. (2020) Anal dysplasia and anal cancer. English versionAnale Dysplasien und Analkarzinom. Der Hautarzt 71:S2, pages 74-81.
Crossref
Zheng Quan Toh, Laura He, Catherine Chen, Angela Huang, Fiona M. Russell, Suzanne M. Garland, Rita Reyburn, Tupou Ratu, Evelyn Tuivaga, Ian H. Frazer, E. Kim Mulholland & Paul V. Licciardi. (2020) Measurement of Human Papillomavirus-Specific Antibodies Using a Pseudovirion-Based ELISA Method. Frontiers in Immunology 11.
Crossref
D. I. Zabolotny, M. B. Sambur, T. D. Savchenko, L. D. Krіvokhatskaуа, T. A. Zayets & M. D. Tymchenko. (2020) Dynamics of immunological reactivity indices in patients with laryngal papillomatosis at different periods after complex treatment with antivirus qudrivalent vaccine "Gardasil". Medicni perspektivi (Medical perspectives) 25:3, pages 87-95.
Crossref
Mauro Tognon, Andrea Tagliapietra, Federica Magagnoli, Chiara Mazziotta, Lucia Oton-Gonzalez, Carmen Lanzillotti, Fortunato Vesce, Carlo Contini, John Charles Rotondo & Fernanda Martini. (2020) Investigation on Spontaneous Abortion and Human Papillomavirus Infection. Vaccines 8:3, pages 473.
Crossref
Xu Zhou, Lihua Sun, Xiaoxiao Yao, Guangquan Li, Yicun Wang & Yang Lin. (2020) Progress in Vaccination of Prophylactic Human Papillomavirus Vaccine. Frontiers in Immunology 11.
Crossref
Saule Balmagambetova, Andrea Tinelli, Ospan A. Mynbaev, Arip Koyshybaev, Olzhas Urazayev, Nurgul Kereyeva & Elnara Ismagulova. (2020) Human Papillomavirus Selected Properties and Related Cervical Cancer Prevention Issues. Current Pharmaceutical Design 26:18, pages 2073-2086.
Crossref
Ralph-Sydney Mboumba Bouassa, Hélène Péré, Camélia Gubavu, Thierry Prazuck, Mohammad-Ali Jenabian, David Veyer, Jean-François Meye, Antoine Touzé & Laurent Bélec. (2020) Serum and cervicovaginal IgG immune responses against α7 and α9 HPV in non-vaccinated women at risk for cervical cancer: Implication for catch-up prophylactic HPV vaccination. PLOS ONE 15:5, pages e0233084.
Crossref
Steven Kent Mann & Karl Kingsley. (2020) Human Papillomavirus (HPV) Vaccine Knowledge, Awareness and Acceptance among Dental Students and Post-Graduate Dental Residents. Dentistry Journal 8:2, pages 45.
Crossref
Laura Pizzatti, Caterina Ferreli, Brunella Conti, Laura Atzori, Giampietro Pinna, Luca Pilloni & Franco Rongioletti. (2020) Childhood erythrodermic lichen planus pemphigoides after nonavalent human papillomavirus vaccination. JAAD Case Reports 6:5, pages 431-433.
Crossref
Ulrike Wieland, Frank Oellig & Alexander Kreuter. (2020) Anale Dysplasien und AnalkarzinomAnal dysplasia and anal cancer. Der Hautarzt 71:4, pages 284-292.
Crossref
Giancarlo Icardi, Claudio Costantino, Marcello Guido, Antonella Zizza, Vincenzo Restivo, Daniela Amicizia, Federico Tassinari, Maria Francesca Piazza, Chiara Paganino, Alessandra Casuccio, Francesco Vitale, Filippo Ansaldi & Cecilia Trucchi. (2020) Burden and Prevention of HPV. Knowledge, Practices and Attitude Assessment Among Pre-Adolescents and their Parents in Italy. Current Pharmaceutical Design 26:3, pages 326-342.
Crossref
Francesco Nicoli, Barbara Mantelli, Eleonora Gallerani, Valentina Telatin, Irene Bonazzi, Peggy Marconi, Riccardo Gavioli, Liliana Gabrielli, Tiziana Lazzarotto, Luisa Barzon, Giorgio Palù & Antonella Caputo. (2020) HPV-Specific Systemic Antibody Responses and Memory B Cells are Independently Maintained up to 6 Years and in a Vaccine-Specific Manner Following Immunization with Cervarix and Gardasil in Adolescent and Young Adult Women in Vaccination Programs in Italy. Vaccines 8:1, pages 26.
Crossref
Tjaša Dimčić, Kristina Fujs Komloš, Mario Poljak, Rajko Kavalar & Vesna Breznik. (2020) Digital squamous cell carcinoma associated with possibly carcinogenic human papillomavirus type 73 (HPV73): a case report. Acta Dermatovenerologica Alpina Pannonica et Adriatica 29:4.
Crossref
Jorma Paavonen, Suzanne M. Garland & David Jenkins. 2020. Human Papillomavirus. Human Papillomavirus 299 325 .

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.